Established in December 2022 and headquartered in Mohali, Punjab. The aim is to make cost effective biotech products for healthcare domain specifically in gene & cell therapy (CGT), Sub unit Vaccines and recombinant enzymes. Our domain knowledge and expertise in research, process development and commercial scale give us an edge to tackle challenges associated with development of Biotech/biological product(s). The promoters have the combined experience of approx. 50 years in biotech field with a able team to support the vision of the company. Cancer being a dreaded disease world over is responsible for millions of death globally. The existing therapies are very costly and cause serious side effects. Invigorate Bio propose to develop cost effective cell and gene therapy products using efficient viral vectors systems (LVV). To support India’s Once health mission and making healthcare affordable to everyone, Invigorate Bio wish to develop various vaccines viz. Pneumococcal conjugate vaccine (20 valent), Hib-TT conjugate vaccine, Meningococcal conjugate Vaccine, HPV, Hepatitis B vaccine, rTyphoid, Dengue, JE, mRNA vaccine, Influenza vaccine etc. using platform technologies